How many insider declarations has Mandel-Brehm Josh filed?

Mandel-Brehm Josh has filed 3 public insider declarations with SEC (Form 4).

What is Mandel-Brehm Josh's role?

Mandel-Brehm Josh's reported role is not specified by the regulator across the filings.

Which companies does Mandel-Brehm Josh report trades for?

Mandel-Brehm Josh reports trades for Camp4 Therapeutics Corp.

What is Mandel-Brehm Josh's declared buy vs sell volume?

Across the available history, declared buys total 18k€ and disposals 0.

← Executives ★ Sign in to follow

MJ

Mandel-Brehm Josh

CEO

·SEC (Form 4)

Camp4 Therapeutics Corp

0

申报总数

0

公司

€17,892

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the complete record of transactions filed by Mandel-Brehm Josh. Director active across 1 company, notably Camp4 Therapeutics Corp. In total, 3 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €18k. History available since 11 September 2025. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.

Companies and markets linked to Mandel-Brehm Josh

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Camp4 Therapeutics Corp (US)

申报3 总计

▲

Mandel-Brehm Josh

Chief Executive Officer高管2026年8月3日Camp4 Therapeutics Corp

US$10,80957SEC ↗

6,551 股@ US$1.650.0060% mcap52.4% 占其流量Common StockSEC:0001628280-26-053505:0

标准退出：2026年11月1日 (T+90)

▲

Mandel-Brehm Josh

Chief Executive Officer高管2025年9月11日Camp4 Therapeutics Corp

US$9,99952SEC ↗

6,060 股@ US$1.65100.0% 占其流量Common StockSEC:0001927058-25-000002:0

标准退出：2025年12月10日 (T+90)

●

Mandel-Brehm Josh

Chief Executive Officer高管2024年10月15日Camp4 Therapeutics Corp

22SEC ↗

605 股Common StockSEC:0001104659-24-108699:0

3 条申报中的 3 条

InsidersTradesSigma

← Executives ★ Sign in to follow

MJ

Mandel-Brehm Josh

CEO

·SEC (Form 4)

Camp4 Therapeutics Corp

0

申报总数

0

公司

€17,892

▲ 买入（2 笔）

—

▼ 卖出（0 笔）

内部人交易记录

其他

已披露买入

2

已披露卖出

0

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Browse the complete record of transactions filed by Mandel-Brehm Josh. Director active across 1 company, notably Camp4 Therapeutics Corp. In total, 3 reports have been recorded. Breakdown: 2 buys · 0 sell. Total volume traded: €18k. History available since 11 September 2025. The latest transaction was filed on 3 August 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.